Federal Circuit affirms Roxane’s patent not infringed

18-11-2016

The US Court of Appeals for the Federal Circuit has affirmed a district court’s ruling holding that Camber Pharmaceuticals and Invagen Pharmaceuticals do not infringe Roxane Laboratories’ patent.


Roxane Laboratories, patent, Camber Pharmaceuticals, Invagen,

LSIPR